CVD weekly pick
2026 ESC Guidelines for the management of heart failure.
European heart journal. 2026 Aug 28;:.
0
LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: The AMUNDSEN Randomized Clinical Trial.
JAMA. 2026 Aug 29;:.
0
Gene Silencer Therapy in Transthyretin Amyloid Cardiomyopathy: A Meta-Analysis of Outcomes Trials.
JAMA. 2026 Aug 30;:.
0
The kidney in the middle: Kidney Disease: Improving Global Outcomes (KDIGO) guidelines address multiple key components of cardiovascular-kidney-metabolic syndrome.
Kidney international. 2026 Sep;110(3):570-582.
0
2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.
Journal of the American College of Cardiology. 2026 Aug 25;88(8):856-890.
0
International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2026 Sep;45(9):1357-1374.
0
Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50%: The CMR GUIDE Randomized Clinical Trial.
JAMA. 2026 Aug 28;:.
0
Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial.
Lancet (London, England). 2026 Aug 29;:.
0
From prescription to persistence: guideline-recommended medical therapy in heart failure with reduced ejection fraction.
European heart journal. 2026 Aug 24;47(32):4459-4461.
0
Coronary Artery Calcium in ACC/AHA Prevention Guidelines: Evolution From 2007 to 2026.
JACC. Cardiovascular imaging. 2026 Aug 29;:.
0
2026 AHA/ACC guideline for the evaluation and management of acute pulmonary embolism in adults.
Journal of hospital medicine. 2026 Sep 3;:.
0
Management of Peripheral Artery Disease in Adults With Diabetes: 2025 ACC Scientific Statement: A Report of the American College of Cardiology.
Journal of the American College of Cardiology. 2026 Aug 25;88(8):891-906.
0
HRS scientific statement on artificial intelligence integration framework into clinical electrophysiology workflows.
Heart rhythm. 2026 Sep;23(9):e2235-e2250.
0
Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial.
JAMA internal medicine. 2026 Aug 30;:.
0
LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: The AMUNDSEN Randomized Clinical Trial.
JAMA. 2026 Aug 29;:.
0
Adverse pregnancy outcomes and long-term cardiovascular disease risk.
Lancet (London, England). 2026 Sep 5;408(10558):952-968.
0
Oral Relaxin Receptor Agonist AZD5462 in Participants With Chronic Heart Failure: Primary Results From the LUMINARA Trial.
Circulation. 2026 Aug 30;:.
0
Guidelines for Prevention and Management of Complications of Injection Drug Use- A WikiGuidelines Group Consensus Statement.
The American journal of medicine. 2026 Aug 27;:.
0
Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.
The New England journal of medicine. 2026 Aug 30;:.
0
2026 American Association for Thoracic Surgery (AATS) expert consensus statement: Antithrombotic management of neonates/infants undergoing cardiac interventions.
The Journal of thoracic and cardiovascular surgery. 2026 Sep;172(3):618-662.e7.
0
.